Accord Launches Landmark Study to Redefine Mental Health Treatment at its Metabolic Roots
ACCORD is proud to announce that the Baszucki Group has awarded more than $600,000 in research funding to support a groundbreaking study on metabolic psychiatry in partnership with McLean Hospital. This three-year project, led by Dr. Virginie-Anne Chouinard and Dr. Matthew Bernstein, along with a dedicated research assistant and biostatistician, will explore how ketogenic and other metabolic interventions influence psychiatric symptoms, metabolic health and overall functioning.
Read more here!
Baszucki Group today announced the launch of the Metabolic Mind Fresh Start Award to empower individuals who have fought hard to win back their mental health. The Award honors the courage, strength, and resilience of individuals who have implemented ketogenic therapy to treat a serious mental illness. Awardees will receive a one-time prize of $10,000 to help them reach their goals.
Read more
Metabolic Mind celebrates Hope and Resiliency with Fresh Start Awards for individuals using ketogenic therapy to reclaim their mental health Metabolic Mind, a nonprofit initiative of Baszucki Group,...
Read more
A one-year prospective study found that very high cholesterol in 100 otherwise metabolically healthy individuals on a ketogenic diet for an average of 5 years did not correlate...
Read more